Drug Development: Regulatory & Clinical Strategies for Australia and China (Invite-Only)

Drug Development: Regulatory & Clinical Strategies for Australia and China   Tuesday, September 29, 2026 3:30 PM – 6:00 PM  Sheraton Valley Forge Hotel in King of Prussia  This is an exclusive, invite-only roundtable program for approximately 15 participants from emerging biotech companies. Designed for executive and functional leaders involved in early-stage development, the discussion will focus on the critical decisions that shape a product’s path to global markets.  Participants will gain a deeper understanding of how regulatory strategy, clinical trial design, and study location selection can influence development timelines, future market opportunities, and overall program success. Our speakers include senior development and regulatory experts from Thermo Fisher Scientific who have supported biotech companies navigating development pathways across Australia and China. Following the roundtable, attendees are invited to join the Life Sciences Future Welcome Happy Hour from 5:00 PM to 6:00 PM, which will include drinks, appetizers, and networking with conference attendees, sponsors, investors, and industry leaders. The roundtable and reception are designed to complement one another, providing an opportunity to continue conversations and build new connections with the broader life sciences community.  You do not need to be registered for the conference to attend.  There is no fee or other obligation associated with attending, but seating is limited. This roundtable is intended to provide a valuable educational and networking opportunity for biotech leaders navigating the complexities of global development.